Bf te2

cTBNA is being performed at our facility since 2006 while EBUS-TBNA was started in June 2011.[3 (link), 15 (link)] cTBNA procedures were performed by operators under direct supervision of the consultants. The procedure was performed on an outpatient basis till December 2012 under topical anesthesia alone and from January 2013 onwards under topical anesthesia and conscious sedation (intravenous midazolam and pentazocine in doses sufficient to maintain sedation and cough control).[12 (link), 13 (link)] Subjects were administered 0.6 mg atropine and 25 mg promethazine intramuscularly followed by nebulized lignocaine (4% solution) immediately before the procedure. Topical 10% lignocaine was sprayed over the oropharynx augmented with 2% lignocaine solution instilled over the vocal cords and the airways.[16 (link)] Monitoring of pulse rate, respiratory rate and pulse oximetric saturation was performed throughout the procedure.
A flexible bronchoscope (BF-1T20, BF-TE2, BF-1T150 or BF-IT 180, Olympus, Japan; FB-19TV, Pentax, Japan) was used to perform cTBNA, as described previously.[13 (link)] Smears were prepared on glass slides and sent for cytopathological examination and cultures. Rapid on-site cytologic evaluation (ROSE) was not available.